ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2026
Can Alpha-Glucosidase Activity in Plasma or Leukocytes Serve as a Biomarker for Future Gene Therapy in Classic Infantile Pompe Disease?
Martha C Faraguna et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.